JACC. Heart failure Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Cardiovascular Risk Factors and Genetic Risk in Transthyretin V142I Carriers. 2024
• Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure. 2024
• Relationship Between Myocardial NPPB Expression and Serum NT-proBNP in Heart Failure With Preserved Ejection Fraction..  12:1306-1308. 2024
• Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial..  12:999-1011. 2024
• Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series..  12:795-809. 2024
• Health Status in Heart Failure and Cancer: Analysis of the Medicare Health Outcomes Survey 2016-2020..  12:1166-1178. 2023
• Physical Activity Trajectories Preceding Incident Heart Failure: A Proof-of-Concept Study..  12:232-234. 2023
• Clinical Inertia Among Outpatients With Heart Failure: Application of Treatment Nonintensification Taxonomy to EPIC-HF Trial..  11:1579-1591. 2023
• Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF..  12:757-767. 2023
• Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways..  11:1231-1242. 2023
• Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction..  11:918-929. 2023
• Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status..  11:1380-1393. 2023
• Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype..  11:1000-1010. 2023
• Pre-Heart Failure Longitudinal Change in a Hispanic/Latino Population-Based Study: Insights From the Echocardiographic Study of Latinos..  11:946-957. 2023
• Role of a Novel Self-Reported Questionnaire for Frailty Assessment in HFpEF..  11:404-406. 2023
• Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction..  11:1103-1117. 2023
• Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel..  10:889-901. 2022
• Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HF..  10:918-927. 2022
• Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies..  10:583-594. 2022
• Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study..  10:485-493. 2022
• A Standardized and Regionalized Network of Care for Cardiogenic Shock..  10:768-781. 2022
• Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure..  10:498-507. 2022
• Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial..  10:266-275. 2022
• Depressive Symptoms and Incident Heart Failure Risk in the Southern Community Cohort Study..  10:254-262. 2022
• Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults..  10:129-138. 2021
• Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction..  9:747-757. 2021
• Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults..  9:484-493. 2021
• Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure..  9:471-481. 2021
• Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial..  9:325-335. 2021
• Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes..  9:215-223. 2021
• Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study..  9:179-189. 2020
• A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock..  8:879-891. 2020
• Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis..  8:712-724. 2020
• Nutrition, Heart Failure, and Quality of Life: Beyond Dietary Sodium..  8:765-769. 2020
• Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community..  8:640-653. 2020
• Reply: Toward Improved Understanding of Potential Harm in Heart Failure..  8:247-248. 2020
• Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction..  7:1029-1031. 2019
• Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods..  7:1079-1088. 2019
• Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management..  7:1001-1011. 2019
• Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics..  7:1032-1041. 2019
• Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction..  7:1056-1065. 2019
• Healthy Aging and Cardiovascular Function: Invasive Hemodynamics During Rest and Exercise in 104 Healthy Volunteers..  8:111-121. 2019
• Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization..  8:25-34. 2019
• Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults..  7:394-401. 2019
• Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction..  7:321-332. 2019
• Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry..  7:350-358. 2019
• Amyloidosis of the Brain and Heart: Two Sides of the Same Coin?.  7:129-131. 2019
• Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction..  6:975-982. 2018
• Frequency of Transition From Stage A to Stage B Heart Failure After Initiating Potentially Cardiotoxic Chemotherapy..  6:1023-1032. 2018
• Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF..  6:1008-1010. 2018
• Weighty Matters in HFpEF and Aging..  6:650-652. 2018
• Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction..  6:640-649. 2018
• The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF..  6:701-709. 2018
• Rising Mortality in Patients With Heart Failure in the United States: Facts Versus Fiction..  6:610-612. 2018
• Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2..  6:633-639. 2018
• The Mediterranean Diet to Treat Heart Failure: A Potentially Powerful Tool in the Hands of Providers..  6:-. 2018
• Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis..  6:117-126. 2018
• Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study..  5:724-734. 2017
• Body Mass Index and Cardiorespiratory Fitness in Mid-Life and Risk of Heart Failure Hospitalization in Older Age: Findings From the Cooper Center Longitudinal Study..  5:367-374. 2017
• A Multibiomarker Approach to Heart Failure Prognostication: A Work in Progress..  5:265-267. 2017
• A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study..  5:359-366. 2017
• Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study..  5:347-355. 2017
• Unraveling the Relationship Between Aging and Heart Failure With Preserved Ejection Fraction: The Importance of Exercise and Normative Reference Standards..  5:356-358. 2017
• Obesity and Survival With Heart Failure: Still a Paradox..  5:64-66. 2017
• Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation..  5:44-52. 2017
• Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study..  5:157-165. 2016
• Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes..  4:935-946. 2016
• Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION..  4:617-24. 2016
• Impaired Alveolar Capillary Membrane Diffusion: A Recently Recognized Contributor to Exertional Dyspnea in Heart Failure With Preserved Ejection Fraction..  4:499-501. 2016
• Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance..  4:636-45. 2016
• Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..  4:649-61. 2016
• Gait Speed: Stepping Towards Improved Assessment of Heart Failure Patients..  4:299-300. 2016
• Bulking Up Skeletal Muscle to Improve Heart Failure Prognosis..  4:274-6. 2016
• One Week of Daily Dosing With Beetroot Juice Improves Submaximal Endurance and Blood Pressure in Older Patients With Heart Failure and Preserved Ejection Fraction..  4:428-37. 2016
• Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study..  3:542-550. 2015
• Hospitalizations and Prognosis in Elderly Patients With Heart Failure and Preserved Ejection Fraction: Time to Treat the Whole Patient..  3:442-444. 2015
• Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study)..  3:445-455. 2015
• Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device..  3:965-76. 2015
• Does low bone mineral density cause a broken heart?.  2:390-1. 2014
• Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure..  2:260-8. 2014
• Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study..  2:238-46. 2014
• The burden of acute heart failure on U.S. emergency departments..  2:269-77. 2014
• Cardiac rehabilitation exercise and self-care for chronic heart failure..  1:540-7. 2013
• Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk..  1:353-360. 2013
• Chronotropy: the Cinderella of heart failure pathophysiology and management..  1:267-9. 2013
• Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)..  1:142-8. 2013

Identity

International Standard Serial Number (ISSN)

• 2213-1787